P-tau231 as a diagnostic biomarker for Alzheimer's Disease and mild cognitive impairment: A systematic review and meta-analysis

Objective: Some previous studies have shown that cerebrospinal fluid (CSF) levels of p-tau231 were significantly higher in patients with Alzheimer's disease (AD) compared to that in patients with mild cognitive impairment (MCI) and normal control (NC), whereas some other studies did not. Due to...

Full description

Bibliographic Details
Main Authors: Fardin Nabizadeh, Negin Salehi, Elham Ramezannezhad, Shaghayegh Sadeghmousavi, Elham Khalili
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=5;spage=845;epage=851;aulast=Nabizadeh